Camber Pharmaceuticals Appoints Scott Hettenhausen as Vice President of Rx Sales

Camber Pharmaceuticals is pleased to announce the appointment of Scott Hettenhausen as Vice President of Rx Sales. Scott will lead Camber’s generics sales team, oversee product sales, and strengthen customer relationships.
“Camber is excited to welcome Scott to our leadership team,” said Kon Ostaficiuk, President of Camber Pharmaceuticals. “His extensive experience in the generic pharmaceutical industry, deep knowledge of supply chain operations, and strong reputation with customers will be instrumental in advancing our mission to deliver affordable, high-quality medicines.”
Scott is a seasoned pharmaceutical executive with more than 28 years of industry experience. He has held senior leadership roles at organizations including Express Scripts, Econdisc Contracting Solutions, Walgreens Boots Alliance Development, Cigna and D&K Healthcare Resources.
Scott holds a Bachelor of Science in Biology from Southern Illinois University and a Master of Business Administration (MBA) from Webster University.
Read more about Camber’s leadership team here.
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection